No change in hepatitis C virus-specific T cell functionality after successful DAA treatment in chronic hepatitis C patients

Geahča maid

• Immune responses in DAA treated chronic hepatitis C patients with and without prior RG-101 dosing
  Dahkki: van der Ree, M, et al.
  Almmustuhtton: (2017)
• Immune phenotype and function of NK and T cells in chronic hepatitis C patients who received a single dose of anti-miR-122, RG-101.
  Dahkki: Stelma, F, et al.
  Almmustuhtton: (2017)
• A single dose of anti-miR-122, RG-101, in CHC patients results in NK cell normalization with no effect on HCV-specific CD8+ T cell function
  Dahkki: Stelma, F, et al.
  Almmustuhtton: (2017)
• “Waiting for DAAs”: A retrospective chart review of patients with untreated hepatitis C in Rwanda
  Dahkki: Gupta, N, et al.
  Almmustuhtton: (2017)
• An update on hepatitis C virus.
  Dahkki: Klenerman, P, et al.
  Almmustuhtton: (2015)